XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Millions
Total
Bausch Health Companies Inc. Shareholders’ Deficit
Common Shares
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Non- controlling Interest
Beginning Balance (in shares) at Dec. 31, 2023     365,200,000        
Beginning Balance at Dec. 31, 2023 $ (82) $ (1,022) $ 10,423 $ 214 $ (9,778) $ (1,881) $ 940
Increase (Decrease) in Shareholders' Equity              
Common shares issued under share-based compensation plans (in shares)     1,800,000        
Common shares issued under share-based compensation plans 0   $ 60 (60)      
Share-based compensation 69 69   69      
Employee withholding taxes related to share-based awards (18) (18)   (18)      
Vesting of B+L equity compensation 0 (24)   (24)     24
Net income (loss) (78) (54)     (54)   (24)
Other comprehensive income (loss) (118) (126)       (126) 8
Ending Balance (in shares) at Jun. 30, 2024     367,000,000.0        
Ending Balance at Jun. 30, 2024 (227) (1,175) $ 10,483 181 (9,832) (2,007) 948
Beginning Balance (in shares) at Mar. 31, 2024     366,700,000        
Beginning Balance at Mar. 31, 2024 (174) (1,115) $ 10,480 164 (9,842) (1,917) 941
Increase (Decrease) in Shareholders' Equity              
Common shares issued under share-based compensation plans (in shares)     300,000        
Common shares issued under share-based compensation plans 0   $ 3 (3)      
Share-based compensation 36 36   36      
Employee withholding taxes related to share-based awards (4) (4)   (4)      
Vesting of B+L equity compensation 0 (12)   (12)     12
Net income (loss) (1) 10     10   (11)
Other comprehensive income (loss) (84) (90)       (90) 6
Ending Balance (in shares) at Jun. 30, 2024     367,000,000.0        
Ending Balance at Jun. 30, 2024 $ (227) (1,175) $ 10,483 181 (9,832) (2,007) 948
Beginning Balance (in shares) at Dec. 31, 2024 367,843,058   367,800,000        
Beginning Balance at Dec. 31, 2024 $ (322) (1,279) $ 10,490 234 (9,824) (2,179) 957
Increase (Decrease) in Shareholders' Equity              
Common shares issued under share-based compensation plans (in shares)     1,900,000        
Common shares issued under share-based compensation plans 0   $ 20 (20)      
Share-based compensation 89 89   89      
Employee withholding taxes related to share-based awards (19) (19)   (19)      
Vesting of B+L equity compensation 0 (34)   (34)     34
Noncontrolling interest distributions (9)           (9)
Net income (loss) 42 90     90   (48)
Other comprehensive income (loss) $ 366 389       389 (23)
Ending Balance (in shares) at Jun. 30, 2025 369,749,489   369,700,000        
Ending Balance at Jun. 30, 2025 $ 147 (764) $ 10,510 250 (9,734) (1,790) 911
Beginning Balance (in shares) at Mar. 31, 2025     369,500,000        
Beginning Balance at Mar. 31, 2025 (240) (1,183) $ 10,508 220 (9,882) (2,029) 943
Increase (Decrease) in Shareholders' Equity              
Common shares issued under share-based compensation plans (in shares)     200,000        
Common shares issued under share-based compensation plans 0   $ 2 (2)      
Share-based compensation 46 46   46      
Employee withholding taxes related to share-based awards (3) (3)   (3)      
Vesting of B+L equity compensation 0 (11)   (11)     11
Noncontrolling interest distributions (9)           (9)
Net income (loss) 128 148     148   (20)
Other comprehensive income (loss) $ 225 239       239 (14)
Ending Balance (in shares) at Jun. 30, 2025 369,749,489   369,700,000        
Ending Balance at Jun. 30, 2025 $ 147 $ (764) $ 10,510 $ 250 $ (9,734) $ (1,790) $ 911